Verrica Pharmaceuticals annual gross margin
2022
2023
2024
2025
Verrica Pharmaceuticals Gross Margin Growth & History (VRCA)
Verrica Pharmaceuticals's gross margin was 90.33% for fiscal 2025.
View full Verrica Pharmaceuticals company overviewVerrica Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 90.33% | +24.69 pp |
| 2024 | 2024-12-31 | 65.64% | −24.61 pp |
| 2023 | 2023-12-31 | 90.24% | −1.73 pp |
| 2022 | 2022-12-31 | 91.97% | — |
Verrica Pharmaceuticals quarterly gross margin
Q3.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 85.02% | −11.09 pp |
| Q1 2026 | 2026-03-31 | 82.30% | +2.66 pp |
| Q4 2025 | 2025-12-31 | 72.49% | +205.04 pp |
| Q3 2025 | 2025-09-30 | 92.27% | — |
| Q2 2025 | 2025-06-30 | 96.11% | +9.63 pp |
| Q1 2025 | 2025-03-31 | 79.65% | −2.06 pp |
| Q4 2024 | 2024-12-31 | −132.56% | — |
| Q2 2024 | 2024-06-30 | 86.48% | — |
| Q1 2024 | 2024-03-31 | 81.70% | — |
| Q3 2023 | 2023-09-30 | 89.72% | — |
Verrica Pharmaceuticals gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Verrica Pharmaceuticals's gross margin decreased from 91.97% to 90.33%, a change of −1.64 percentage points. The latest reported quarter, Q2 2026, shows 85.02%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Verrica Pharmaceuticals source filings ↗